|
1
|
Yang Y, Zhou Y, Hou J, Bai C, Li Z, Fan J,
Ng IOL, Zhou W, Sun H, Dong Q, et al: Hepatic IFIT3 predicts
interferon-α therapeutic response in patients of hepatocellular
carcinoma. Hepatology. 66:152–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng AL, Kang YK, Lin DY, Park JW, Kudo
M, Qin S, Chung HC, Song X, Xu J, Poggi G, et al: Sunitinib versus
sorafenib in advanced hepatocellular cancer: Results of a
randomized phase III trial. J Clin Oncol. 31:4067–4075. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JH, Tate CM, You JS and Skalnik DG:
Identification and characterization of the human Set1B histone
H3-Lys4 methyltransferase complex. J Biol Chem. 282:13419–13428.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duncan EM, Chitsazan AD, Seidel CW and
Alvarado AS: Set1 and MLL1/2 target distinct sets of functionally
different genomic loci in vivo. Cell Rep. 17:9302016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Han J, Zhang Y, Cao F, Liu Z, Li S,
Wu J, Hu C, Wang Y, Shuai J, et al: Structural basis for activity
regulation of MLL family methyltransferases. Nature. 530:447–452.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang BL, Ji X, Yu LX, Gao Y, Xiao CH, Liu
J, Zhao DX, Le Y, Diao GH, Sun JY, et al: Somatic mutation
profiling of liver and biliary cancer by targeted next generation
sequencing. Oncol Lett. 16:6003–6012. 2018.PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li J, Wu H, Li W, Yin L, Guo S, Xu X,
Ouyang Y, Zhao Z, Liu S, Tian Y, et al: Downregulated miR-506
expression facilitates pancreatic cancer progression and
chemoresistance via SPHK1/Akt/NF-κB signaling. Oncogene.
35:5501–5514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Davie JR, Xu W and Delcuve GP: Histone
H3K4 trimethylation: Dynamic interplay with pre-mRNA splicing.
Biochem Cell Biol. 94:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang W and Ernst P: Distinct functions of
histone H3, lysine 4 methyltransferases in normal and malignant
hematopoiesis. Curr Opin Hematol. 24:322–328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hiraide T, Nakashima M, Yamoto K, Fukuda
T, Kato M, Ikeda H, Sugie Y, Aoto K, Kaname T, Nakabayashi K, et
al: De novo variants in SETD1B are associated with intellectual
disability, epilepsy and autism. Hum Genet. 137:95–104. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt K, Zhang Q, Tasdogan A, Petzold A,
Dahl A, Arneth BM, Slany R, Fehling HJ, Kranz A, Stewart AF and
Anastassiadis K: The H3K4 methyltransferase Setd1b is essential for
hematopoietic stem and progenitor cell homeostasis in mice. Elife.
7:e271572018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Redd PS, Ibrahim ML, Klement JD, Sharman
SK, Paschall AV, Yang D, Nayak-Kapoor A and Liu K: SETD1B activates
iNOS expression in myeloid-derived suppressor cells. Cancer Res.
77:2834–2843. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brici D, Zhang Q, Reinhardt S, Dahl A,
Hartmann H, Schmidt K, Goveas N, Huang J, Gahurova L, Kelsey G, et
al: Setd1b, encoding a histone 3 lysine 4 methyltransferase, is a
maternal effect gene required for the oogenic gene expression
program. Development. 144:2606–2617. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin H, Min Z and Tao Q: The MLL/Setd1b
methyltransferase is required for the Spemann's organizer gene
activation in Xenopus. Mech Dev. 142:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Choi YJ, Oh HR, Choi MR, Gwak M, An CH,
Chung YJ, Yoo NJ and Lee SH: Frameshift mutation of a histone
methylation-related gene SETD1B and its regional heterogeneity in
gastric and colorectal cancers with high microsatellite
instability. Hum Pathol. 45:1674–1681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Medjkane S, Cock-Rada A and Weitzman JB:
Role of the SMYD3 histone methyltransferase in tumorigenesis: Local
or global effects? Cell Cycle. 11:18652012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang B, Qi G, Tang F, Yuan S, Wang Z,
Liang X, Li B, Yu S, Liu J, Huang Q, et al: JARID1B promotes
metastasis and epithelial-mesenchymal transition via PTEN/AKT
signaling in hepatocellular carcinoma cells. Oncotarget.
6:12723–12739. 2015. View Article : Google Scholar : PubMed/NCBI
|
